DR RECKEWEG BC-1 description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

DR RECKEWEG BC-1

PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO

Dr. Reckeweg BC-1




FULL PRESCRIBING INFORMATION

Active ingredient

Each tablet contains: /

Chaque comprimé contient:

Purpose

Enter section text here

Enter section text here

Uses

For the temporary relief of minor symptoms associated with iron deficiency.

Caution: Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner before use if you are pregnant or breastfeeding. Do not use if safety seal is broken.

Mise en garde: Consulter un praticien de la santé si les symptômes persistent ou s'aggravent.  Consulter un praticien de la santé avant l'usage si vous êtes enceinte ou si vous allaitez. Ne pas utiliser si le sceau de sécurité est brisé.

Dosage:

Adults and children > 12 years 4 tablets; children (6-11 years) 2 tablets; children (1-5 years) 1 tablet, all ages take 4 times daily or as directed by a health care practitioner. For children under 5 years of age, dissolve tablet in water.

Posologie: Adultes et enfants > 12 ans 4 comprimés; enfants (6-11 ans) 2 comprimés; enfants (1-5 ans) 1 comprimé, tous les âges prendre 4 fois par jour ou selon les directives d'un praticien de la santé.  Pour les enfants de moins de 5 ans, dissoudre le comprimé dans l'eau.

Non-medicinal ingredients:

croscarmellose sodium, monohydrate lactose, magnesium stearate.

Ingrédients non-médicinaux:

croscarmellose sodium, lactose monohydrate, stéarate de magnésium.

DR RECKEWEG BC-1

NDC # 53346-1201-2

Dr. Reckeweg BC-1

Homeopathic medicine

for the temporary relief of minor symptoms associated with iron deficiency

Manufactured in Germany by:
Pharmazeutische Fabrik Dr. Reckeweg Co. GmbH D-64625 Bensheim
www.reckeweg.de

200 tablets
20 g

DR RECKEWEG BC-1

CALCAREA PHOSPHORICA, FERRUM PHOSPHORICUM, KALI PHOSPHORICUM, NATRUM MURIATICUM TABLET

Product Information

Product Type Human otc drug label Item Code (Source) NDC:53346-1201
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TRIBASIC CALCIUM PHOSPHATE CALCIUM CATION 3 [hp_X]
FERROSOFERRIC PHOSPHATE Ferrosoferric Phosphate 3 [hp_X]
potassium phosphate, dibasic PHOSPHATE ION 3 [hp_X]
SODIUM CHLORIDE 6 [hp_X]

Inactive Ingredients

Ingredient Name Strength
MAGNESIUM STEARATE
CROSCARMELLOSE SODIUM
LACTOSE

Product Characteristics

Color Size Imprint Code Shape
white (white) 5 mm nothing ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:53346-1201-2 20 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2012-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.